An analysis of FDA-approved drugs for oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An analysis of FDA-approved drugs for oncology

Published:2014-12 Issue:12 Volume:19 Page:1831-1835
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Kinch Michael S.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference21 articles.

1. Cancer Crusade: The Story of the National Cancer Act of 1971;Rettig,2005

2. Toxicology and pharmacology of the chemical warfare agent sulfur mustard;Dacre;Pharmacol. Rev.,1996

3. The initial clinical trial of nitrogen mustard;Gilman;Am. J. Surg.,1963

4. Disaster at Bari;Infield,1974

5. An anniversary for cancer chemotherapy;Hirsch;JAMA,2006

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical and toxicity evaluation of Retama sphaerocarpa extracts and in-silico investigation of phenolic compounds as potential inhibitors against HPV16 E6 oncoprotein;Fitoterapia;2024-06

2. Small molecule anticancer drugs approved during 2021–2022: Synthesis and clinical applications;European Journal of Medicinal Chemistry;2024-06

3. Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan‐cancer analysis;Cancer Medicine;2024-02

4. The Effective Synthesis of New Benzoquinoline Derivatives as Small Molecules with Anticancer Activity;Pharmaceuticals;2023-12-28

5. Overview of drugs approved by the FDA in 2022;Pharmacy & Pharmacology;2023-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP